Emmune Inc

Emmune, Inc. is a burgeoning biotechnology start-up based in Jupiter, Florida. Consisting of a small team of five employees, the company is focused on developing innovative solutions for the treatment and prevention of HIV infection. Emmune's core product is a synthetic antibody called "eCD4-Ig," engineered from the receptors HIV utilizes to infect T cells, CD4 and CCR5. This unique design grants eCD4-Ig the ability to recognize all known HIV-1 isolates. The company has demonstrated the efficacy of eCD4-Ig in pre-clinical studies, achieving remarkable results in protecting monkeys from multiple live virus challenges following a single intramuscular inoculation with an AAV vector expressing the antibody. Emmune's approach holds significant promise for revolutionizing HIV treatment and prevention strategies. For more information about Emmune's groundbreaking work, visit their website at emmun.bio.